Dr. Juan C. Almagro is the RnD director of UDIBI. He is an expert in the fields of antibody engineering and development of biologic therapeutics, with over twenty-five years of experience in the Pharma/Biotech Industry and academic settings.

In the Pharma/Biotech industry occupied positions of Sr. Director at Pfizer, and Scientific Director and Head of Antibody Design at Johnson & Johnson. In academia, was Visiting Scientist at Fred Hutchinson Cancer Research Center, Invited Professor at Simon Fraser University and Associate Professor at The National University of Mexico.

Supported in part by the National Science Foundation (NSF) founded GlobalBio, Inc. in 2014 to develop and apply novel protein engineering methods to antibody therapeutic development. Based on these methods, have signed, and executed numerous contracts with startups, clinical-stage biotechnology companies and large biopharmaceutical organizations to discover, optimize and develop antibody-based therapeutics with application in Immuno-Oncology, Oncology, and Infectious Diseases.

Author of eighty-seven publications, including fifty-one peer-reviewed scientific articles, six book chapters and thirty patents. Regular reviewer for Immunology, Bioinformatics and Protein Engineering journals, as well as for grant agencies in several countries. Chaired and have given talks and lectures at major domestic and international scientific meetings.